Data Therapy Collection to Evaluate Performances of an Automated Insulin Titration Algorithm Compared to Standard Method of Titration

A data collection of blood glucose values, insulin, meal composition will be performed for a period of two months, to evaluate the performances of an automated insulin titration algorithm

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Uhmontpellier

Montpellier, 34295, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Person with Type 1 diabetes
Treated by basal-bolus therapy with MDI or pump
Patient with social security or beneficiary of medical coverage
Patient using functional insulin therapy or starting and education course
Patient able to read and understand the procedure, and able to express consent for study protocol

Exclusion criteria

Patient abusing substances
Patient deprived of liberty by judicial or administrative decision, person subject to a legal protection measure, patient having a psychological condition making him unable to follow and understand study protocol

Treatment and study plan

Primary outcomes

evaluate the performances of an insulin titration algorithm

Time frame: day 1

to evaluate the performances of an insulin titration algorithm to calculate insulin therapy parameters at the same precision of an expert practitioner

Secondary outcomes

measure time-in-range evolution adjustment of insulin therapy parameters

Time frame: day 1

to measure time-in-range evolution before and after adjustment of insulin therapy parameters by practitioner

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Registry information

Acronym: GLUCAL3

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: Oct 28, 2021
Registry last updated: Oct 24, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed